SFX by Ex Libris Inc.

Title:	Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products
Source:	European Journal of Clinical Pharmacology [0031-6970] A., Ceci yr:2002

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Saint Raymond, A. "Development of medicines for children in Europe: ethical implications." Paediatric respiratory reviews 6.1 (2005): 45-51.
description	2.	Steinbrook, R. "Testing medications in children." The New England journal of medicine 347.18 (2002): 1462-4.
description	3.	't Jong, G W W. "Lack of effect of the European guidance on clinical investigation of medicines in children." Acta pædiatrica 91.11 (2002): 1233-8.
description	4.	Leader, G. "Antibiotic prescribing rates in the US ambulatory care setting for patients diagnosed with influenza, 1997-2001." Respiratory medicine 98.11 (2004): 1093-1101.
description	5.	Impicciatore, P. "Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric use." British journal of clinical pharmacology 48.1 (1999): 15-8.
description	6.	Koren, G. "Use of healthy children as volunteers in drug studies: the ethical debate." Clinical pharmacology and therapeutics 73.3 (2003): 147-52.
description	7.	Soellner, L. "The need for juvenile animal studies – a critical review." Regulatory toxicology and pharmacology 65.1 (2012): 87-99.
description	8.	Pandit, S. "Inappropriate oral formulations and information in paediatric trials." Archives of Disease in Childhood 95.9 (2010): 754-756.
description	9.	Rutschmann, Olivier T. "Antibiotics for upper respiratory tract infections in ambulatory practice in the United States, 1997-1999: does physician specialty matter?" The journal of the American Board of Family Practice 17.3 (2004): 196-200.
description	10.	Lemon, Stephenie C. "Variations in Influenza Vaccination Among the Elderly." American Journal of Health Behavior 28.4 (2004): 352-360.
description	11.	Kelley, M. "Antibiotic prescriptions associated with outpatient visits for acute upper respiratory tract infections among adult Medicaid recipients in North Carolina." North Carolina medical journal (2003): 148-56.
description	12.	Dunne, J. "The European Regulation on medicines for paediatric use." Paediatric respiratory reviews 8.2 (2007): 177-83.
description	13.	Rossi, A. "Inappropriate use of anti-asthmatic drugs in the Italian paediatric population." European journal of clinical pharmacology 59.7 (2003): 565-569.
description	14.	Flum, David R R. "The clinical and economic correlates of misdiagnosed appendicitis: nationwide analysis." Archives of surgery 137.7 (2002): 799-804.
description	15.	Kauffman, R E E. "Clinical trials in children: problems and pitfalls." Paediatric drugs 2.6 (2000): 411-8.
description	16.	Ceci, A. "Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years." European journal of clinical pharmacology 62.11 (2006): 947-52.
description	17.	Nundy, S. "A new colonialism?--Conducting clinical trials in India." The New England journal of medicine 352.16 (2005): 1633-1636.
description	18.	Conroy, S. "Unlicensed and off-label drug use: issues and recommendations." Paediatric drugs 4.6: 353-359.
description	19.	de Vries, L T W T. "Lack of appropriate formulations of medicines for children in the community." Acta pædiatrica 92.12 (2004): 1486-9.
description	20.	Caldwell, Patrina H Y H. "Clinical trials in children." Lancet, The 364.9436 (2004): 803-11.